Kave Niksefat is senior vice president, Global Marketing and Access. He is responsible for providing commercial leadership for Amgen products at all stages of the product lifecycle and for maximizing value across the portfolio. He leads four commercial therapeutic area teams – Oncology, Inflammation, General Medicine, and Rare Disease – in addition to Global Value, Access & Policy, and Commercial Business Development.

Niksefat joined Amgen in 2015 and has served in a number of commercial leadership roles across Amgen’s portfolio including vice president and global therapeutic area head for Rare Disease, vice president and general manager of the U.S. Inflammation business unit, and vice president and head of U.S. Value & Access. Prior to joining Amgen, Niksefat spent a decade in management consulting primarily focused on the life sciences industry.

Niksefat holds a bachelor’s degree from the Price School of Policy at the University of Southern California (USC) and a master’s degree from USC’s Marshall School of Business.